ScienceNew federal autism committee chair reportedly has financial ties to leucovorin
STAT reports that the new chair, John Gaitanis, founded a startup to help autistic children access leucovorin, a drug the outlet says lacks evidence for use as an autism treatment.
TLDR
STAT reports that RFK Jr. appointed pediatric neurologist John Gaitanis to chair the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2 billion in autism research. The outlet reports that Gaitanis founded a startup to help autistic children access leucovorin and says the drug lacks evidence for use as an autism treatment.
New federal autism committee chair reportedly has financial ties to leucovorin
STAT reports that the new chair, John Gaitanis, founded a startup to help autistic children access leucovorin, a drug the outlet says lacks evidence for use as an autism treatment.
TLDR
STAT reports that RFK Jr. appointed pediatric neurologist John Gaitanis to chair the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2 billion in autism research. The outlet reports that Gaitanis founded a startup to help autistic children access leucovorin and says the drug lacks evidence for use as an autism treatment.